Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 2,026.00
+27.00 (1.35%)
Jun 27, 2025, 5:49 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 4.47 billion as of June 27, 2025. Its market cap has increased by 2.01% in one year.
Market Cap
4.47B
Enterprise Value
5.35B
Revenue
2.50B
Ranking
n/a
PE Ratio
15.75
Stock Price
2,026.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.47B, an increase of 850.93%. That is a compound annual growth rate of 12.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 163.56B |
| GSK plc | 56.88B |
| Haleon | 33.99B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.91B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.34B |
| Oxford Nanopore Technologies | 1.30B |